GB959261A - Ergoline i derivatives - Google Patents

Ergoline i derivatives

Info

Publication number
GB959261A
GB959261A GB1998762A GB1998762A GB959261A GB 959261 A GB959261 A GB 959261A GB 1998762 A GB1998762 A GB 1998762A GB 1998762 A GB1998762 A GB 1998762A GB 959261 A GB959261 A GB 959261A
Authority
GB
United Kingdom
Prior art keywords
alkyl
cycloaliphatic
methyl
hydrogen
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1998762A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT85562A external-priority patent/IT1051702B/en
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Priority claimed from IT1570063A external-priority patent/IT1051709B/en
Publication of GB959261A publication Critical patent/GB959261A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention comprises D-6-methyl- and 1,6-dimethyl-8-aminomethyl-ergoline I derivatives of general formula: <FORM:0959261/C2/1> wherein R1 is hydrogen or methyl and R is hydrogen or the radical of an aliphatic, cycloaliphatic, aromatic, aralkyl, aralkenyl, heterocyclyl-alkyl, cycloaliphatic-alkyl or heterocyclic carboxylic, dicarboxylic, carbamic, carbonic or sulphonic acid, having from 1 to 10 carbon atoms substituted or not by aryloxy groups or halogen atoms, by free or monoalkylated or dialkylated amino groups, by nitro, hydroxy, alkyl, alkoxy, thioether or sulphonic groups; and their preparation by reduction of the corresponding dihydro-D-lysergamides and, if desired, subsequent acylation with the chloride or anhydride of the appropriate acid. Pharmaceutical compositions comprise compounds of the invention with a therapeutically acceptable carrier. Oral and parenteral administration (tablets, powders, pills, liquids) are mentioned. The compounds have oxytocic, antienteraminic, adrenolytic, hypotensive and sedative properties. Specifications 670,991 and 811,964 are referred to.
GB1998762A 1961-05-29 1962-05-24 Ergoline i derivatives Expired GB959261A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT980861 1961-05-29
IT1617861 1961-09-07
IT85562A IT1051702B (en) 1962-01-18 1962-01-18 REFINEMENTS RELATED TO 6 METHYL AND 1.6 DIMETHYL ERGOLINE DERIVATIVES 1
IT1570063A IT1051709B (en) 1963-07-26 1963-07-26 1-methyl-n-carbobenzoxy-dihydrolysergamine

Publications (1)

Publication Number Publication Date
GB959261A true GB959261A (en) 1964-05-27

Family

ID=27452643

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1998762A Expired GB959261A (en) 1961-05-29 1962-05-24 Ergoline i derivatives
GB3069464A Expired GB1004310A (en) 1961-05-29 1964-08-04 1,6-dimethyl-ergoline i derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB3069464A Expired GB1004310A (en) 1961-05-29 1964-08-04 1,6-dimethyl-ergoline i derivatives

Country Status (10)

Country Link
BE (1) BE650930A (en)
BR (2) BR6239435D0 (en)
CH (1) CH430737A (en)
DE (2) DE1470217A1 (en)
FI (2) FI45660C (en)
FR (3) FR1326772A (en)
GB (2) GB959261A (en)
NL (3) NL6408237A (en)
NO (1) NO118975B (en)
SE (2) SE315903B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299836A (en) * 1979-07-12 1981-11-10 Richter Gedeon Vegyeszeti Gyar Rt. Novel ergol-8-ene and ergolin compounds and process for preparing same
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
US4766128A (en) * 1983-03-14 1988-08-23 Schering Aktiengesellschaft Optionally 11- to 13-substituted ergoline compounds useful as medicinal agents
EP0411494A2 (en) * 1989-08-04 1991-02-06 POLI INDUSTRIA CHIMICA S.p.A. Ergoline derivatives having dopaminergic activity
US7572883B2 (en) 2001-06-08 2009-08-11 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Somatostatin-dopamine chimeric analogs
US8952128B2 (en) 2012-11-01 2015-02-10 Ipsen Pharma S.A.S. Somatostatin-dopamine chimeric analogs

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1513322A (en) * 1976-01-09 1978-06-07 Farmaceutici Italia Heterocyclic ergoline derivatives

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299836A (en) * 1979-07-12 1981-11-10 Richter Gedeon Vegyeszeti Gyar Rt. Novel ergol-8-ene and ergolin compounds and process for preparing same
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
US4766128A (en) * 1983-03-14 1988-08-23 Schering Aktiengesellschaft Optionally 11- to 13-substituted ergoline compounds useful as medicinal agents
EP0411494A2 (en) * 1989-08-04 1991-02-06 POLI INDUSTRIA CHIMICA S.p.A. Ergoline derivatives having dopaminergic activity
EP0411494A3 (en) * 1989-08-04 1991-04-24 Poli Industria Chimica S.P.A. Ergoline derivatives having dopaminergic activity
US7572883B2 (en) 2001-06-08 2009-08-11 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Somatostatin-dopamine chimeric analogs
US7579435B2 (en) 2001-06-08 2009-08-25 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Somatostatin-dopamine chimeric analogs
US8178651B2 (en) 2001-06-08 2012-05-15 Ipsen Pharma, S.A.S. Somatostatin-dopamine chimeric analogs
US8324386B2 (en) 2001-06-08 2012-12-04 Ipsen Pharma S.A.S. Somatostatin-dopamine chimeric analogs
US8952128B2 (en) 2012-11-01 2015-02-10 Ipsen Pharma S.A.S. Somatostatin-dopamine chimeric analogs
US9603942B2 (en) 2012-11-01 2017-03-28 Ipsen Pharma S.A.S. Somatostatin-dopamine chimeric analogs
US9731027B2 (en) 2012-11-01 2017-08-15 Ipsen Pharma S.A.S. Somatostatin-dopamine chimeric analogs

Also Published As

Publication number Publication date
FR1326772A (en) 1963-04-01
SE324784B (en) 1970-06-15
NL6408237A (en) 1965-01-27
FI45660B (en) 1972-05-02
FR98F (en)
FI46507C (en) 1973-04-10
FI45660C (en) 1972-08-10
GB1004310A (en) 1965-09-15
SE315903B (en) 1969-10-13
NO118975B (en) 1970-03-09
CH430737A (en) 1967-02-28
BR6461039D0 (en) 1973-08-14
DE1470285A1 (en) 1970-07-02
BE650930A (en) 1964-11-16
NL278401A (en)
FR2075M (en) 1963-10-14
BR6239435D0 (en) 1973-06-14
NL128196C (en)
FI46507B (en) 1973-01-02
DE1470217A1 (en) 1969-12-11

Similar Documents

Publication Publication Date Title
GB981827A (en) Lumilysergol derivatives
ES2095942T3 (en) BENZENOACETAMIDE DERIVATIVES HIV INHIBITORS.
GB1392275A (en) Therapeutic compositions
GB959261A (en) Ergoline i derivatives
NZ212588A (en) Pharmaceutical compositions contai indole derivatives, and certain of these derivatives
GB1457022A (en) Esters of oxyalkyltheophyllines the preparation thereof and pharmaceutical compositions containint them
IL75239A0 (en) Beta-lactam antibiotics,their preparation,pharmaceutical compositions containing them and their use as growth-promoters in livestock rearing or as antioxidants
GB1252870A (en)
GB1191099A (en) Ergoline Derivatives
GB1523598A (en) Tripeptides
GB1530074A (en) Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents
GB1194505A (en) Piperidinol Derivatives and Process for Preparing Them
GB1494560A (en) 4-aryl-5-aminoalkyl-4-thiazolin-2-ones and their preparation
GB1123768A (en) New thebaine and oripavine derivatives and processes for preparing the same
GB1280290A (en) Novel derivatives of benzhydrylpiperazine, their process of preparation and their therapeutic application
GB962857A (en) Process for the production of imides
GB1250348A (en)
GB985004A (en) 6-methyl-ergoline i derivatives
GB1100444A (en) 13-alkyl 17-halogenoalkynyl steroid 3-alcohols and their esters
GB1319841A (en) Quinine alkaloid derivatives
GB1002005A (en) New benzanilide derivatives
GB949523A (en) ºÔ-(acyloxyphenoxy)-benzoic acid derivatives
GB1139146A (en) Benzofuran derivatives and processes for preparing the same
ES366690A1 (en) 15(r)-pge1 and related compounds
GB1060466A (en) Improvements in or relating to novel anthracene derivatives